Patent · US Active

Inhibitors of CXCR2

US8552033B2 · kind B2 · utility

0Cited by

3References

10Claims

0Family size

Assignee

Sanofi · FR

Inventors

Stephanie Hachtel · Frankfurt am Main, DE
Juergen Dedio · Frankfurt, DE
Stephen Shimshock · Fryeburg, US
Carolina Lanter · Audubon, US

Key dates

Filing date	Dec 17, 2008
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Dec 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of the formula Iin which R1, R2, X, A, B and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.